Long-Acting Opioid Painkiller Arymo Wins FDA Approval
(Reuters) January 2017
The U.S. Food and Drug Administration said on Monday it has approved Egalet Corp.’s long-acting opioid painkiller, Arymo ER.
The decision follows the recommendation of an independent panel of advisors to the FDA, which in August voted 18-1 in favor of approval. The panel recommended the drug be labeled as an abuse-deterrent product.
The FDA did not immediately say whether it has granted the abuse-deterrent label. Egalet’s shares were halted pending news after rising 15% to $9.12 earlier in the day.
The abuse of opioids, a class of drugs that include heroin and prescription painkillers, has reached epidemic proportions in the United States. The Centers for Disease Control and Prevention estimates that 78 Americans die every day from an opioid overdose.
Arymo ER is a long-acting variation of morphine that is intended to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment. It comes in the form of a very hard pill that is difficult to crush and otherwise manipulate by people looking to abuse the product.
Chewing, crushing, dissolving and injecting opioids can increase the speed with which the drugs get into the bloodstream and deliver the sought-after high.
Lawmakers across the United States are seeking ways to stem the epidemic and the FDA is trying to encourage the development of abuse-resistant opioid formulations. The same advisory panel also recommended that the FDA approve a long-acting opioid made by Teva Pharmaceutical Industries Ltd., Vantrela ER.
It also recommended approval of a long-acting, abuse-deterrent opioid made by Pfizer Inc., Troxyca ER, though it had reservations about the drug’s ability to curb all forms of abuse.
Categories
- Benefits Resources
- Bonding
- BOP
- Business Insurance
- Commercial Auto
- Commercial Property
- Company News
- Construction
- Crime Insurance
- Cyber Insurance
- Directors & Officers
- Employee Benefits
- Employment Practice Liability Insurance
- Entertainment
- General Liability
- Health Insurance
- Healthcare
- Healthcare Reform
- Homeowners Insurance
- Hospitality
- Manufacturing
- Medical Malpractice
- Mining & Energy
- Nightclubs
- Personal Auto
- Personal Insurance
- Professional
- Restaurants
- Retail & Wholesale
- Risk Management Resources
- Safety Topics
- SBA Bonds
- Security
- Seminars
- Technology
- Tourism
- Transportation
- Uncategorized
- Workers Compensation
Archives
- May 2021
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- November 2018
- September 2018
- August 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- February 2013
- November 2011
- October 2011
- September 2011
- July 2011
- June 2011
- March 2011
- November 2010
- October 2010
- September 2010
- April 2010
- February 2010
- November 2009
- October 2009
- November 2008
- August 2008